BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27866532)

  • 1. [Evaluation of disease free survival after radical resection for primary duodenal adenocarcinoma].
    Jiang QL; Huang XH; Zhang JW; Zhang SS; Wang CF
    Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(42):3393-3397. PubMed ID: 27866532
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.
    Chang ST; Jeffrey RB; Patel BN; DiMaio MA; Rosenberg J; Willmann JK; Olcott EW
    Radiology; 2016 Dec; 281(3):816-825. PubMed ID: 27438167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
    Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
    Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.
    Kim MJ; Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Suh SO; Choi SY
    Kaohsiung J Med Sci; 2014 May; 30(5):254-9. PubMed ID: 24751389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of preoperative abdominal contrast-enhanced multiple-row detector computed tomography in predicting the postoperative 1-year disease-free survival for gastric cancer].
    Feng C; Cheng J; Xiang H; Hong N; Ye Y; Wang Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1059-1064. PubMed ID: 30269328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after surgical resection for duodenal adenocarcinoma in the UK.
    Solaini L; Jamieson NB; Metcalfe M; Abu Hilal M; Soonawalla Z; Davidson BR; McKay C; Kocher HM;
    Br J Surg; 2015 May; 102(6):676-81. PubMed ID: 25776995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of 54 cases of primary malignant duodenal tumor].
    Sun JJ; Wu ZY
    Zhonghua Wai Ke Za Zhi; 2004 Mar; 42(5):276-8. PubMed ID: 15062015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
    Cao X; Yu T; Zhao G; Xiao G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Node negative duodenal adenocarcinoma is associated with long-term patient survival following pancreaticoduodenal resection.
    Patel PH; Likos-Corbett M; Doyle J; Kumar S; Bhogal RH
    ANZ J Surg; 2022 May; 92(5):1105-1109. PubMed ID: 35403794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
    Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
    Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma.
    Mann K; Gilbert T; Cicconi S; Jackson R; Whelan P; Campbell F; Halloran C; Neoptolemos J; Ghaneh P
    Langenbecks Arch Surg; 2019 Jun; 404(4):439-449. PubMed ID: 30972486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up.
    Lian PL; Chang Y; Xu XC; Zhao Z; Wang XQ; Xu KS
    World J Gastroenterol; 2017 Aug; 23(30):5579-5588. PubMed ID: 28852317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in patients with duodenal adenocarcinoma.
    Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
    ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-free survival following resection in non-ductal periampullary cancers: A retrospective multicenter analysis.
    Bourgouin S; Ewald J; Mancini J; Moutardier V; Delpero JR; Le Treut YP
    Int J Surg; 2017 Jun; 42():103-109. PubMed ID: 28461144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical surgical management of periampullary duodenal adenocarcinoma: a single institution experience.
    Bhatti AB; Yosuf MA; Syed AA
    J Pak Med Assoc; 2014 Nov; 64(11):1260-4. PubMed ID: 25831642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Ratio, Perineural Invasion and R1 Resection as Independent Prognostic Factors in Pancreatic Adenocarcinoma: A Retrospective Cohort Study.
    Di Martino M; Ielpo B; de Nova JLM; Muñoz EA; Santamaria C; Diago V; Martín-Pérez E
    Surg Technol Int; 2020 May; 36():82-88. PubMed ID: 32190897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
    Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.